PubRank

Martin Kaiser

Author PubWeight™ 28.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Angiogenesis in multiple myeloma. Eur J Cancer 2006 1.31
2 Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment. Eur J Haematol 2006 1.27
3 Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma. Blood 2006 1.22
4 Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. Eur J Haematol 2006 1.21
5 Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma. Eur J Haematol 2007 1.11
6 Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment. Eur J Haematol 2008 1.10
7 Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function. Biochem Biophys Res Commun 2005 1.07
8 Proteasome: an emerging target for cancer therapy. Anticancer Drugs 2005 1.04
9 Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease. Biochem Biophys Res Commun 2005 0.99
10 High-yield synthesis and structure of double-walled bismuth-nanotubes. Nano Lett 2010 0.98
11 Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. Blood 2011 0.97
12 Improved risk stratification in myeloma using a microRNA-based classifier. Br J Haematol 2013 0.95
13 Decrease in CD4+ T-cell counts in patients with multiple myeloma treated with bortezomib. Clin Lymphoma Myeloma Leuk 2010 0.93
14 Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA). Exp Cell Res 2007 0.93
15 Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated I kappaB kinase. J Cancer Res Clin Oncol 2008 0.93
16 Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK. Br J Haematol 2007 0.90
17 Development and validation of a paediatric long-bone fracture classification. A prospective multicentre study in 13 European paediatric trauma centres. BMC Musculoskelet Disord 2011 0.87
18 High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia. Leuk Res 2011 0.87
19 The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases. Eur J Haematol 2012 0.86
20 Bone markers in multiple myeloma. Eur J Cancer 2006 0.85
21 Prenatal management of an allantoic cyst with patent urachus. Arch Gynecol Obstet 2009 0.84
22 Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma. Anticancer Drugs 2006 0.82
23 Molecular and clinical aspects of proteasome inhibition in the treatment of cancer. Recent Results Cancer Res 2007 0.80
24 Quenching of the upconversion luminescence of NaYF₄:Yb³⁺,Er³⁺ and NaYF₄:Yb³⁺,Tm³⁺ nanophosphors by water: the role of the sensitizer Yb³⁺ in non-radiative relaxation. Nanoscale 2015 0.80
25 Gut-derived factors promote neurogenesis of CNS-neural stem cells and nudge their differentiation to an enteric-like neuronal phenotype. Am J Physiol Gastrointest Liver Physiol 2011 0.79
26 Water dispersible upconverting nanoparticles: effects of surface modification on their luminescence and colloidal stability. Nanoscale 2015 0.78
27 Calcium responses to synaptically activated bursts of action potentials and their synapse-independent replay in cultured networks of hippocampal neurons. Biochim Biophys Acta 2013 0.78
28 Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma. Exp Cell Res 2009 0.76
29 BSc2118 is a novel proteasome inhibitor with activity against multiple myeloma. Eur J Haematol 2010 0.76
30 A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue. Leuk Lymphoma 2014 0.76
31 Absolute photoluminescence quantum yields of IR26 and IR-emissive Cd(1-x)Hg(x)Te and PbS quantum dots--method- and material-inherent challenges. Nanoscale 2015 0.76
32 Molecular phylogenetic relationship of snow finch complex (genera Montifringilla, Pyrgilauda, and Onychostruthus) from the Tibetan plateau. Mol Phylogenet Evol 2006 0.75
33 The Intermetalloid Cluster Cation (CuBi8)3. Chemistry 2017 0.75
34 [Limitations and possibilities of applying the positive effects of human/animal relations in the treatment of psychological ailments]. Bull Soc Sci Med Grand Duche Luxemb 2005 0.75
35 Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia. Leuk Res 2010 0.75